Alerts will be sent to your verified email
Verify EmailCHANDRAP
|
Chandra Prabhu Intl
|
Radford Global
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
6.99 % | 1.27 % | 0.85 % |
|
5yr average Equity Multiplier
|
2.81 | 1.15 | 1.01 |
|
5yr Average Asset Turnover Ratio
|
2.07 | 0.55 | 0.02 |
|
5yr Avg Net Profit Margin
|
-0.09 % | 1.92 % | -19.83 % |
|
Price to Book
|
2.9 | 2.07 | 0.39 |
|
P/E
|
0.0 | 321.43 | 45.31 |
|
5yr Avg Cash Conversion Cycle
|
85.67 Days | 136.94 Days | 0.0 |
|
Inventory Days
|
64.77 Days | 328.67 Days | 0.0 |
|
Days Receivable
|
55.27 Days | 55.38 Days | 0.0 |
|
Days Payable
|
50.45 Days | 84.73 Days | 3.0 Days |
|
5yr Average Interest Coverage Ratio
|
1.33 | 1543.57 | 902.8 |
|
5yr Avg ROCE
|
4.49 % | 1.85 % | 0.2 % |
|
5yr Avg Operating Profit Margin
|
0.22 % | -1.23 % | -19.88 % |
|
5 yr average Debt to Equity
|
1.07 | 0.01 | 0.0 |
|
5yr CAGR Net Profit
|
n/a | 31.95 % | -28.94 % |
|
5yr Average Return on Assets
|
0.18 % | 1.07 % | 0.19 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
54.34 % | 7.36 % | 0.0 |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.21 % | 0.0 | 0.0 |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 0.0 | 0.0 |
|
Chandra Prabhu Intl
|
Radford Global
|
Biogen Pharmachem
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|